230 related articles for article (PubMed ID: 31048367)
1. LRNA9884, a Novel Smad3-Dependent Long Noncoding RNA, Promotes Diabetic Kidney Injury in
Zhang YY; Tang PM; Tang PC; Xiao J; Huang XR; Yu C; Ma RCW; Lan HY
Diabetes; 2019 Jul; 68(7):1485-1498. PubMed ID: 31048367
[TBL] [Abstract][Full Text] [Related]
2. Novel lncRNA Erbb4-IR Promotes Diabetic Kidney Injury in
Sun SF; Tang PMK; Feng M; Xiao J; Huang XR; Li P; Ma RCW; Lan HY
Diabetes; 2018 Apr; 67(4):731-744. PubMed ID: 29222368
[TBL] [Abstract][Full Text] [Related]
3. AANG Prevents Smad3-dependent Diabetic Nephropathy by Restoring Pancreatic β-Cell Development in db/db Mice.
Chung JY; Tang PM; Chan MK; Wang L; Huang XR; To KF; Ma RC; Lan HY
Int J Biol Sci; 2022; 18(14):5489-5502. PubMed ID: 36147472
[TBL] [Abstract][Full Text] [Related]
4. Treatment for type 2 diabetes and diabetic nephropathy by targeting Smad3 signaling.
He H; Wang H; Chen X; Zhong Y; Huang XR; Ma RC; Wang C; Lan HY
Int J Biol Sci; 2024; 20(1):200-217. PubMed ID: 38164169
[TBL] [Abstract][Full Text] [Related]
5. Deletion of Smad3 prevents renal fibrosis and inflammation in type 2 diabetic nephropathy.
Xu BH; Sheng J; You YK; Huang XR; Ma RCW; Wang Q; Lan HY
Metabolism; 2020 Feb; 103():154013. PubMed ID: 31734275
[TBL] [Abstract][Full Text] [Related]
6. C-Reactive Protein Promotes Diabetic Kidney Disease in db/db Mice via the CD32b-Smad3-mTOR signaling Pathway.
You YK; Huang XR; Chen HY; Lyu XF; Liu HF; Lan HY
Sci Rep; 2016 May; 6():26740. PubMed ID: 27221338
[TBL] [Abstract][Full Text] [Related]
7. Identification of novel long noncoding RNAs associated with TGF-β/Smad3-mediated renal inflammation and fibrosis by RNA sequencing.
Zhou Q; Chung AC; Huang XR; Dong Y; Yu X; Lan HY
Am J Pathol; 2014 Feb; 184(2):409-17. PubMed ID: 24262754
[TBL] [Abstract][Full Text] [Related]
8. Monocyte chemoattractant protein-1-induced tissue inflammation is critical for the development of renal injury but not type 2 diabetes in obese db/db mice.
Chow FY; Nikolic-Paterson DJ; Ma FY; Ozols E; Rollins BJ; Tesch GH
Diabetologia; 2007 Feb; 50(2):471-80. PubMed ID: 17160673
[TBL] [Abstract][Full Text] [Related]
9. Long Noncoding RNA Arid2-IR Is a Novel Therapeutic Target for Renal Inflammation.
Zhou Q; Huang XR; Yu J; Yu X; Lan HY
Mol Ther; 2015 Jun; 23(6):1034-1043. PubMed ID: 25743111
[TBL] [Abstract][Full Text] [Related]
10. Long Non-coding RNA LRNA9884 Promotes Acute Kidney Injury via Regulating NF-kB-Mediated Transcriptional Activation of MIF.
Zhang Y; Tang PM; Niu Y; García Córdoba CA; Huang XR; Yu C; Lan HY
Front Physiol; 2020; 11():590027. PubMed ID: 33192605
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-29b inhibits diabetic nephropathy in db/db mice.
Chen HY; Zhong X; Huang XR; Meng XM; You Y; Chung AC; Lan HY
Mol Ther; 2014 Apr; 22(4):842-53. PubMed ID: 24445937
[TBL] [Abstract][Full Text] [Related]
12. FOXO3a Protects against Kidney Injury in Type II Diabetic Nephropathy by Promoting Sirt6 Expression and Inhibiting Smad3 Acetylation.
Wang X; Ji T; Li X; Qu X; Bai S
Oxid Med Cell Longev; 2021; 2021():5565761. PubMed ID: 34122724
[TBL] [Abstract][Full Text] [Related]
13. Novel Interplay Between Smad1 and Smad3 Phosphorylation via AGE Regulates the Progression of Diabetic Nephropathy.
Ono H; Abe H; Sakurai A; Ochi A; Tominaga T; Tamaki M; Kishi S; Murakami T; Nagai K; Kohashi M; Doi T
Sci Rep; 2018 Jul; 8(1):10548. PubMed ID: 30002389
[TBL] [Abstract][Full Text] [Related]
14. Smad3 deficiency improves islet-based therapy for diabetes and diabetic kidney injury by promoting β cell proliferation
Wang HL; Wei B; He HJ; Huang XR; Sheng JY; Chen XC; Wang L; Tan RZ; Li JC; Liu J; Yang SJ; Ma RC; Lan HY
Theranostics; 2022; 12(1):379-395. PubMed ID: 34987651
[No Abstract] [Full Text] [Related]
15. Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury.
Chow F; Ozols E; Nikolic-Paterson DJ; Atkins RC; Tesch GH
Kidney Int; 2004 Jan; 65(1):116-28. PubMed ID: 14675042
[TBL] [Abstract][Full Text] [Related]
16. Smad3 deficiency promotes beta cell proliferation and function in
Sheng J; Wang L; Tang PM; Wang HL; Li JC; Xu BH; Xue VW; Tan RZ; Jin N; Chan TF; Huang XR; Ma RC; Lan HY
Theranostics; 2021; 11(6):2845-2859. PubMed ID: 33456576
[No Abstract] [Full Text] [Related]
17. Blocking lysophosphatidic acid receptor 1 signaling inhibits diabetic nephropathy in db/db mice.
Li HY; Oh YS; Choi JW; Jung JY; Jun HS
Kidney Int; 2017 Jun; 91(6):1362-1373. PubMed ID: 28111010
[TBL] [Abstract][Full Text] [Related]
18. Identification of Smad3-related transcriptomes in type-2 diabetic nephropathy by whole transcriptome RNA sequencing.
Zhou Q; Guo H; Yu C; Huang XR; Liang L; Zhang P; Yu J; Zhang J; Chan TF; Ma RCW; Lan HY
J Cell Mol Med; 2021 Feb; 25(4):2052-2068. PubMed ID: 33369170
[TBL] [Abstract][Full Text] [Related]
19. An aqueous extract of Portulaca oleracea ameliorates diabetic nephropathy through suppression of renal fibrosis and inflammation in diabetic db/db mice.
Lee AS; Lee YJ; Lee SM; Yoon JJ; Kim JS; Kang DG; Lee HS
Am J Chin Med; 2012; 40(3):495-510. PubMed ID: 22745066
[TBL] [Abstract][Full Text] [Related]
20. RAGE-Aptamer Blocks the Development and Progression of Experimental Diabetic Nephropathy.
Matsui T; Higashimoto Y; Nishino Y; Nakamura N; Fukami K; Yamagishi SI
Diabetes; 2017 Jun; 66(6):1683-1695. PubMed ID: 28385802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
